US20120207751A1 - Imidazoquinolines as lipid kinase inhibitors - Google Patents

Imidazoquinolines as lipid kinase inhibitors Download PDF

Info

Publication number
US20120207751A1
US20120207751A1 US13/453,225 US201213453225A US2012207751A1 US 20120207751 A1 US20120207751 A1 US 20120207751A1 US 201213453225 A US201213453225 A US 201213453225A US 2012207751 A1 US2012207751 A1 US 2012207751A1
Authority
US
United States
Prior art keywords
yl
methyl
quinolin
phenyl
example
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/453,225
Inventor
Carlos Garcia-Echeverria
Frédéric Stauffer
Pascal Furet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0510390A priority Critical patent/GB0510390D0/en
Priority to GB0510390.8 priority
Priority to PCT/EP2006/004725 priority patent/WO2006122806A2/en
Priority to US91378807A priority
Priority to US12/577,268 priority patent/US7994170B2/en
Priority to US13/165,144 priority patent/US8431592B2/en
Application filed by Novartis AG filed Critical Novartis AG
Priority to US13/453,225 priority patent/US20120207751A1/en
Publication of US20120207751A1 publication Critical patent/US20120207751A1/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FURET, PASCAL, GARCIA-ECHEVERRIA, CARLOS, STAUFFER, FREDERIC
Application status is Abandoned legal-status Critical

Links